Aequus Pharmaceuticals Inc. (AQS.V)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 123.74 Thousand CAD | 31.89% |
| 2022 | 93.82 Thousand CAD | -32.9% |
| 2021 | 139.82 Thousand CAD | 13.38% |
| 2020 | 123.32 Thousand CAD | 2171.54% |
| 2019 | 5429.00 CAD | -57.23% |
| 2018 | 12.69 Thousand CAD | 0.0% |
| 2017 | - CAD | -100.0% |
| 2016 | 1.00 CAD | -100.0% |
| 2015 | 75.25 Thousand CAD | 199.89% |
| 2014 | -75.33 Thousand CAD | -776.44% |
| 2013 | -8596.00 CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 161.78 Thousand CAD | 108.93% |
| 2024 Q1 | 77.43 Thousand CAD | -37.42% |
| 2023 Q3 | 184.35 Thousand CAD | 473.4% |
| 2023 FY | 123.74 Thousand CAD | 31.89% |
| 2023 Q4 | 123.74 Thousand CAD | -32.88% |
| 2023 Q1 | 68.95 Thousand CAD | -26.5% |
| 2023 Q2 | 32.15 Thousand CAD | -53.37% |
| 2022 Q1 | 129.7 Thousand CAD | -7.24% |
| 2022 Q3 | 130.1 Thousand CAD | -16.47% |
| 2022 Q2 | 155.75 Thousand CAD | 20.08% |
| 2022 FY | 93.82 Thousand CAD | -32.9% |
| 2022 Q4 | 93.82 Thousand CAD | -27.89% |
| 2021 Q1 | 109.33 Thousand CAD | -11.34% |
| 2021 FY | 139.82 Thousand CAD | 13.38% |
| 2021 Q4 | 139.82 Thousand CAD | -5.2% |
| 2021 Q3 | 147.49 Thousand CAD | 49.21% |
| 2021 Q2 | 98.85 Thousand CAD | -9.59% |
| 2020 Q2 | 1.00 CAD | 858993459100.0% |
| 2020 Q3 | - CAD | -100.0% |
| 2020 Q4 | 123.32 Thousand CAD | 0.0% |
| 2020 FY | 123.32 Thousand CAD | 2171.54% |
| 2020 Q1 | - CAD | -100.0% |
| 2019 Q3 | 5429.00 CAD | 0.0% |
| 2019 Q1 | 9241.00 CAD | -27.2% |
| 2019 Q2 | 5429.00 CAD | -41.25% |
| 2019 Q4 | 5429.00 CAD | 0.0% |
| 2019 FY | 5429.00 CAD | -57.23% |
| 2018 Q4 | 12.69 Thousand CAD | 1269200.0% |
| 2018 Q2 | - CAD | -100.0% |
| 2018 Q1 | 1.00 CAD | 100.01% |
| 2018 FY | 12.69 Thousand CAD | 0.0% |
| 2018 Q3 | 1.00 CAD | 0.0% |
| 2017 Q4 | -18.97 Thousand CAD | 0.0% |
| 2017 Q1 | - CAD | -100.0% |
| 2017 FY | - CAD | -100.0% |
| 2017 Q2 | 1.00 CAD | 0.0% |
| 2017 Q3 | - CAD | -100.0% |
| 2016 Q1 | - CAD | 100.0% |
| 2016 Q2 | 1.00 CAD | 0.0% |
| 2016 FY | 1.00 CAD | -100.0% |
| 2016 Q4 | 1.00 CAD | 0.0% |
| 2016 Q3 | 1.00 CAD | 0.0% |
| 2015 Q1 | -119.39 Thousand CAD | -58.48% |
| 2015 Q3 | -95.5 Thousand CAD | -55.77% |
| 2015 FY | 75.25 Thousand CAD | 199.89% |
| 2015 Q4 | -94.3 Thousand CAD | 1.25% |
| 2015 Q2 | -61.31 Thousand CAD | 48.65% |
| 2014 Q4 | -75.33 Thousand CAD | -303.59% |
| 2014 Q3 | -18.66 Thousand CAD | 0.0% |
| 2014 Q1 | - CAD | 100.0% |
| 2014 FY | -75.33 Thousand CAD | -776.44% |
| 2013 FY | -8596.00 CAD | 0.0% |
| 2013 Q4 | -8596.00 CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| CanadaBis Capital Inc. | 5.82 Million CAD | 97.877% |
| Decibel Cannabis Company Inc. | 48.7 Million CAD | 99.746% |
| Delivra Health Brands Inc. | 1.47 Million CAD | 91.627% |
| Entourage Health Corp. | 10.01 Million CAD | 98.764% |
| Lifeist Wellness Inc. | 4.51 Million CAD | 97.257% |
| Cannara Biotech Inc. | 33.77 Million CAD | 99.634% |
| Medicure Inc. | 2.9 Million CAD | 95.733% |
| PharmaCielo Ltd. | 2.31 Million CAD | 94.646% |
| Rubicon Organics Inc. | 11.27 Million CAD | 98.903% |
| BioSyent Inc. | 5.89 Million CAD | 97.901% |
| Voyageur Pharmaceuticals Ltd. | 10.32 Thousand CAD | -1098.741% |